In vivo gene delivery to lymph node stromal cells leads to transgene-specific CD8+ T cell anergy in mice. 
Introduction
Antigen presenting cells (APCs) are a functionally heterogeneous population of cells with immunizing or tolerogenic properties. Gene transfer into specific subsets of APC could therefore lead to different immunological outcomes which is important to understand in the context of gene therapy.
Professional APCs such as dendritic cells (DC) are MHC class II+ mobile sentinels specialized in acquiring antigens from the outside and of integrating various signals to trigger specialized effector T cell responses [1] . Stromal cells in tissues or lymphoid organs also function as APCs by presenting endogenous tissue antigens to T cells, playing a key role in self-tolerance in the steady-state [2, 3] .
While most tissue stromal cells only express MHC class I and can only present to CD8 T cells, some A c c e p t e d m a n u s c r i p t subsets of stromal cells express MHC class II. For instance thymic epithelial cells present self-peptides on both MHC class I and class II molecules to shape T cell precursors T cell receptor repertoire by positive selection or clonal deletion [4] . Auto-reactive CD4+ T cells, which escape deletion in the thymus may become anergic through additional peripheral tolerance mechanisms, notably in secondary lymphoid organs (SLO).
SLO like spleen or lymph nodes (LN) are highly-organized structures that bring immune cells in close contact within functionally-defined compartments. It is now clear that stromal cells in SLOs are not only important structural elements that define the traffic of cells and of fluids in the organ, but also control lymphoid homeostasis and T cell responses [2] . In mice, several models show that peripheral CD8+ T cell tolerance is established in LN by direct presentation of self-antigens on MHC class I by LN stromal cells [5] [6] [7] [8] . Recently, SLO stromal cells were also shown to control peripheral CD4+ T cell development. SLO stromal cells can express low levels of constitutive MHC class II molecules, which can be upregulated during immune responses [9] [10]. The functional role of SLO stromal cells in CD4+
T cell activation has been assessed experimentally with transplants of MHC class II-deficient LN combined with T cell transfer. These experiments showed that MHC class II self-antigen presentation by LN stromal cells controls antigen-specific response by maintaining antigen-specific regulatory T cells [11] . It is not known how MHC class II+ stromal cells function in more physiological conditions.
Studying antigenic presentation by LN stroma remains challenging [3] and has not yet been explored via gene transfer.
Recombinant gene transfer lentiviral vectors (LV) are non-inflammatory tools that can be used for in vivo gene delivery. LV can be engineered to express antigens in specific cell types. LV envelope glycoproteins can be engineered for cell-specific entry [12] [13] [14] . In particular, a lentiviral pseudotype specific for murine MHC class II IA d [15, 16] was used in vivo in mice and was shown to efficiently transduce MHC class II+ DC in SLO [17] . 
Results

Transgene expression can be targeted to LN stromal cells with the LV-MHCII-miR vector
To obtain selective gene expression in MHC class II+ SLO stromal APC in vivo and to measure the induced T cell responses, we engineered a new recombinant LV combining 3 key features previously tested in other systems. First, the envelope contained MV glycoproteins displaying a scFv specific for murine MHC class II+ cell recognition. Upon systemic administration, this envelope reduces vector biodistribution in the liver and spleen compared to VSVg, but enables gene transfer into spleen DC [17] .
Second, the cassette expressed the GFP-HY transgene, a neo-antigenic protein enabling the identification of transduced potential APCs by flow cytometry (FACS). The GFP-HY transgene fuses the green fluorescent protein (GFP) with an HY male murine antigen sequence containing the Dby and Uty T cell epitopes. This sequence permits the detection of male-specific CD4+ and CD8+ T cell responses in female mice [17] . Third, GFP-HY transgene expression was regulated by mir142.3p target sequences to prevent antigenic expression in cells of hematopoietic origin and to prevent direct antigenic presentation of the transgene by classical DC [20] . In vitro, the mir142.3p target sequences did not alter the expression of GFP-HY in the HEK293T cell line (data not shown) but prevented it in cultured MHC A c c e p t e d m a n u s c r i p t class II+ spleen cells which contain almost exclusively cells of hematopoietic origin (Figure 1 ). The stroma-targeting vector, abbreviated as LV-MHCII-miR, and its control LV-MHCII previouslycharacterized [17] , differ only by the presence or absence of mir142.3p target sequences. Both vectors were produced using identical methods and titered at similar levels using reverse transcriptase (RT)
concentrations, as described previously [17] . Vectors were compared side by side using the same amount of RT. The LV-MHCII-miR vector leads to T cell hypo-responsiveness.
Consistent with its ability to transduce DC, the control LV-MHCII vector induced robust HY
antigen-specific T cell responses as previously reported [17] . Such T cell responses were higher than 
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Material and methods
Construction and plasmids
The GFP-HY gene cassette containing the coding sequences of the Dby peptide , has been described in [17] . miR142.3p target sequences were obtained from pAAV CMV haSarco_HYmiR142.3pT plasmid [24] and inserted in the transgene cassette after WPRE in XbaI restriction site. The targeting measles glycoproteins envelope plasmids pF∆30 and pHmut∆18-MHC-II were already described [15, 16, 32] . All plasmids were produced and purified using the Nucleobond PC2000EF kit from Macherey-Nagel (Düren, Germany).
Lentiviral vector production and titration
Batches of LV-MHCII and LV-MHCII-miR were produced following transfection of 293 T cells with 5
plasmids using the 2 envelope plasmids already described for the measles pseudotype 
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In-vivo cytotoxic assay
Splenocytes from congenic C57Bl/6 CD45.1 male and female mice were respectively labeled with 0.2µM or 2µM of carboxyfluorescein succinimidyl ester dye (CFSE) in RPMI during 8 minutes in obscurity at room temperature followed by a 2-minutes incubation at 37°C. The reaction was stopped by adding cold RPMI 10% foetal bovine serum (FBS) and placing the cells at 4°C during 5 minutes. Cells were then washed in RPMI 10% FBS and incubated 20 minutes at 37°C to stabilize the marking. Before injection into recipient mice, CFSE-labeled splenocytes were washed 2 times, counted and resuspended at the desired concentration (5x10 6 CFSE low male cells + 5x10 6 
Statistical analysis
Significant differences between mean values were determined using unpaired two-tailed Student's test or Mann-Whitney depending on normality using GraphPad Prism software. P value under 0.05 was considered statistically significant.
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